Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

DIFFERENTIAL ENANTIOSELECTIVITY AND PRODUCT-DEPENDENT ACTIVATION AND INHIBITION IN METABOLISM OF VERAPAMIL BY HUMAN CYP3AS

Lixin Shen, John F. Fitzloff and Chyung S. Cook
Drug Metabolism and Disposition February 2004, 32 (2) 186-196; DOI: https://doi.org/10.1124/dmd.32.2.186
Lixin Shen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John F. Fitzloff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chyung S. Cook
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 2 186-196
DOI 
https://doi.org/10.1124/dmd.32.2.186
PubMed 
14744940

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 24, 2003
  • Accepted September 30, 2003
  • Published online January 26, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Lixin Shen,
  2. John F. Fitzloff and
  3. Chyung S. Cook
  1. Pharmacokinetics, Dynamics and Metabolism, Pfizer, Skokie, Illinois (L.S., C.S.C.); and Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, Illinois (L.S., J.F.F., C.S.C.)
  1. Address correspondence to:
    Dr. Chyung S. Cook, Baxter Healthcare Corporation, WG2-1S, Route 120 and Wilson Road, Round Lake, IL 60073. E-mail: chyung_cook{at}baxter.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to May 2023

AbstractFullPdf
Aug 20171113
Sep 20170165
Oct 20170202
Nov 20170286
Dec 20175166
Jan 201801313
Feb 20180111
Mar 2018087
Apr 20180104
May 20180116
Jun 20180165
Jul 2018178
Aug 2018081
Sep 20180113
Oct 20181711
Nov 2018386
Dec 2018695
Jan 2019422
Feb 2019522
Mar 20191600
Apr 20191921
May 20192123
Jun 2019533
Jul 2019811
Aug 2019911
Oct 20191210
Nov 20192121
Dec 20191653
Jan 20201210
Feb 20201100
Mar 20201111
May 20201312
Jun 20201101
Jul 20201500
Aug 2020301
Sep 2020710
Oct 20202101
Nov 20201600
Dec 20201332
Jan 202112134
Feb 20211172
Mar 20212121
Apr 20211020
May 20211050
Jun 20211342
Jul 2021810
Aug 20211320
Sep 20211030
Oct 2021430
Nov 20211211
Dec 20212110
Jan 20221442
Feb 2022711
Mar 2022410
Apr 20221210
May 20221320
Jun 20222410
Jul 20221041
Aug 20221511
Sep 20221271
Oct 20221230
Nov 20221210
Dec 20222210
Jan 20232040
Feb 20232310
Mar 2023831
Apr 20231411
May 20231230

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (2)
Drug Metabolism and Disposition
Vol. 32, Issue 2
1 Feb 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
DIFFERENTIAL ENANTIOSELECTIVITY AND PRODUCT-DEPENDENT ACTIVATION AND INHIBITION IN METABOLISM OF VERAPAMIL BY HUMAN CYP3AS
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

DIFFERENTIAL ENANTIOSELECTIVITY AND PRODUCT-DEPENDENT ACTIVATION AND INHIBITION IN METABOLISM OF VERAPAMIL BY HUMAN CYP3AS

Lixin Shen, John F. Fitzloff and Chyung S. Cook
Drug Metabolism and Disposition February 1, 2004, 32 (2) 186-196; DOI: https://doi.org/10.1124/dmd.32.2.186

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

DIFFERENTIAL ENANTIOSELECTIVITY AND PRODUCT-DEPENDENT ACTIVATION AND INHIBITION IN METABOLISM OF VERAPAMIL BY HUMAN CYP3AS

Lixin Shen, John F. Fitzloff and Chyung S. Cook
Drug Metabolism and Disposition February 1, 2004, 32 (2) 186-196; DOI: https://doi.org/10.1124/dmd.32.2.186
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CYP3A-mediated oxidation of DABE and BIBR0951
  • Adipocyte PXR does not play an essential role in obesity.
  • Biodistribution of Lipid in Rats
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics